Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-03 10:43:06 - browse：4

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

WSS

Teacher posts viral 'school supply rant' with advice for parents

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Russian and Belarusian players banned from a women's tennis tournament in Prague

STAT series 'Denied by AI' wins major journalism prizes

leisure time

Wikipedia

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Lilly’s weekly insulin works as well as daily products, new studies show

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

BioMarin wins approval for gene therapy to treat hemophilia A

Adidas to release second batch of Yeezy sneakers after breakup with Ye

United colonoscopy coverage change 'may cost lives,' doctors say

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Oak Street deal isn't the answer to health care's woes

explore

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Cherokee Nation medical school graduates its first class

What a koala virus tells us about the human genome

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Hottest summer in 2,000 years puts focus on extreme heat, health

knowledge

knowledge

Wikipedia

hotspot